PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 3142038-0 1988 Effect of auranofin and sodium aurothiomalate on interleukin-1 production from human monocytes in vitro. Auranofin 10-19 interleukin 1 alpha Homo sapiens 49-62 34072916-5 2021 However, auranofin significantly inhibited the levels of NO, monocyte chemoattractant protein-1, and pro-inflammatory cytokines, such as interleukin (IL)-1beta, tumor necrosis factor-alpha, and IL-6, which had been increased by co-treatment with PA and LPS. Auranofin 9-18 interleukin 1 alpha Homo sapiens 137-159 34072916-6 2021 Moreover, the expression of inducible NO synthase, IL-1beta, and IL-6 mRNA and protein levels increased by PA and LPS were reduced by auranofin. Auranofin 134-143 interleukin 1 alpha Homo sapiens 51-59 2125034-1 1990 We have studied the in vitro effects of gold sodium thiomalate (GST) and auranofin (Auf) on the production of interleukin 1 (IL1) expressed as thymocyte co-stimulatory activity (TCSA), and interleukin 1 beta (IL1 beta) as modulated by interferon gamma (IFN gamma). Auranofin 73-82 interleukin 1 alpha Homo sapiens 110-128 32798556-4 2020 Auranofin (AFN), a Txnrd1 inhibitor, decreases IL-1beta levels and increases Nrf2 activation in lipopolysaccharide (LPS) treated alveolar macrophages. Auranofin 0-9 interleukin 1 alpha Homo sapiens 47-55 32798556-4 2020 Auranofin (AFN), a Txnrd1 inhibitor, decreases IL-1beta levels and increases Nrf2 activation in lipopolysaccharide (LPS) treated alveolar macrophages. Auranofin 11-14 interleukin 1 alpha Homo sapiens 47-55 1981242-8 1990 Gold compounds inhibited IL-1 activity, but only auranofin inhibited IL-1 production. Auranofin 49-58 interleukin 1 alpha Homo sapiens 69-73